Protamine Sulphate
Brand names: Protamine Sulphate Injection
Protamine sulphate is the specific intravenous antidote used to neutralise the anticoagulant effect of unfractionated heparin, for example after cardiopulmonary bypass or when reversing therapeutic heparinisation.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a strongly basic protein that binds ionically to acidic heparin molecules, forming an inactive stable complex and thereby abolishing heparin's antithrombin-mediated anticoagulant activity; it only partially reverses low molecular weight heparins.
Prescribing in practice
- Give by slow intravenous injection — rapid administration can cause severe hypotension, bradycardia, flushing and acute pulmonary hypertension, so titrate against the heparin dose still circulating and avoid excess (protamine itself has weak anticoagulant activity in overdose).
- Patients exposed to protamine-containing insulins, those with fish allergy, and men who have had a vasectomy are at higher risk of hypersensitivity and anaphylaxis, so have resuscitation facilities available.
- It only incompletely neutralises low molecular weight heparins and does not reliably reverse fondaparinux, so confirm which anticoagulant is being reversed before dosing.
Monitoring
Monitor activated partial thromboplastin time (or activated clotting time intra-operatively) to confirm reversal, alongside blood pressure, heart rate and signs of anaphylaxis during and after the injection.
Counselling the patient
- Explain this is given by a clinician to switch off the effect of a blood-thinner.
- Report any breathlessness, flushing, rash or feeling faint immediately.
Evidence & guidelines
Its use as the heparin antidote is long-established standard practice supported by the SPC, surgical anticoagulation protocols and UK guidance.
Reference: MHRA SPC Protamine Sulphate; British Society for Haematology LMWH Guidelines; Cardiac Surgery Anticoagulation Protocols; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Revised Cardiac Risk Index (RCRI / Lee Index) · Perioperative Risk
- Vasoactive-Inotropic Score (VIS) · Inotropic Support
- Cardiac Output (Fick Method) · Haemodynamics
- Revised Cardiac Risk Index (RCRI) · Pre-operative Risk
- Duke Activity Status Index (DASI) · Functional Assessment